Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05644522
Other study ID # STU00217395
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 1, 2024
Est. completion date December 2027

Study information

Verified date April 2024
Source Shirley Ryan AbilityLab
Contact Arun Jayaraman, PhD
Phone 312-238-6875
Email ajayaraman@sralab.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to evaluate the impact of using the Nomad powered KAFO in people who have had a musculoskeletal or neurological injury that has affected their ability to walk. The main questions it aims to answer are to quantify the effectiveness of the Nomad in improving mobility, balance, frequency of falls, and quality of life in individuals with lower-extremity impairments compared to their own brace, over three months of daily home and community use. Participants will: - Wear a sensor that records everyday activities and mobility. - Perform measures of mobility and different activities of participation using their own brace. - Perform measures of mobility and different activities of participation using the Nomad powered KAFO


Recruitment information / eligibility

Status Recruiting
Enrollment 36
Est. completion date December 2027
Est. primary completion date December 2027
Accepts healthy volunteers No
Gender All
Age group 18 Years to 89 Years
Eligibility Inclusion Criteria: - Regular and compliant use of a unilateral or bilateral KAFO or SCO or other passive KAFOs for impairment due to neurological or neuromuscular disease, orthopedic disease, or trauma - Cognitive ability to understand and follow the study protocol; willingness to provide informed consent - Willing to wear and charge an activity monitor for three-months home trials. Exclusion Criteria: - Flexion contracture in the knee and/or hip joint in excess of 15 degrees - Non-correctable knee varus/valgus in excess of 15 degrees - Severe spasticity - Inability to stabilize the trunk with or without assistive devices (crutches, canes, etc.)

Study Design


Intervention

Device:
Indego Nomad® Powered Knee-Ankle-Foot Orthosis (P-KAFO) (Parker Hannifin Corp., Cleveland, OH)
The Nomad is a microprocessor-controlled knee-ankle-foot orthosis P-KAFO that incorporates a motor for powered movement assistance and an electronic brake for stance support. The system provides active assistance for knee flexion and extension during the swing phase of gait, reliable stance phase locking at any knee angle, and reliable unlocking without requiring user-generated knee or hip extension torque.

Locations

Country Name City State
United States Shirley Ryan AbilityLab Chicago Illinois

Sponsors (1)

Lead Sponsor Collaborator
Shirley Ryan AbilityLab

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Cross Walk Blinking Signal Test Measuring the time needed to cross a designated street Baseline, Post 3-month home trials with each device
Other Community Mobility Measured by wearing an activity monitor to capture motion / step counts During each 3 month home trial with each device.
Other Self Reported Goals Subjects will be interviewed to understand their self-reported functional goals. Baseline, Post 3-month home trials with each device
Primary Change in 10 Meter Walk Test speed A test to measure the change of speed of both self selected and fastest walking speeds Baseline, Post 3-month home trials with each device
Secondary Six Minute Walk Test A test to measure how much distance is traveled over the course of 6 minutes. Baseline, Post 3-month home trials with each device
Secondary Berg Balance Test A test of standing balance Baseline, Post 3-month home trials with each device
Secondary Functional Gait Assessment A test of postural stability during walking tasks Baseline, Post 3-month home trials with each device
Secondary Hill Assessment Index Used to assess different gait patterns during ascent or descent of slopes Baseline, Post 3-month home trials with each device
Secondary Stair Assessment Index Used to assess functional abilities during ascent and descent of stairs Baseline, Post 3-month home trials with each device
Secondary Timed Up and Go A functional mobility test to measure how long it takes to rise from a chair, walk 3 meters, turn around, and return back to a sitting position in the chair. Baseline, Post 3-month home trials with each device
Secondary Activities Specific Balance Confidence Scale A self-report questionnaire designed to measure fear of falling across 16 items. Baseline, Post 3-month home trials with each device
Secondary Modified Falls Efficacy Scale A self-report questionnaire designed to measure fear of falling across 14 items. Baseline, Post 3-month home trials with each device
Secondary Orthotics and Prosthetics User Survey A self-report questionnaire designed to evaluate the outcome of orthotic and prosthetic services. Baseline, Post 3-month home trials with each device
Secondary World Health Organization Quality of Life A self-report questionnaire that measures an individual's perceived quality of life. Baseline, Post 3-month home trials with each device
Secondary EQ5D-5L A self-report questionnaire that measures quality of life with mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Baseline, Post 3-month home trials with each device
Secondary Numeric Pain Rating Scale A measure of perceived pain intensity Baseline, Post 3-month home trials with each device, and as needed throughout course of study.
Secondary Borg Rate of Perceived Exertion A measure of perceived exertion during an activity Baseline, Post 3-month home trials with each device, and as needed throughout course of study
Secondary Manual Muscle Test A rating of overall gross muscle strength Screening, Baseline, Post 3-month home trials with each device
Secondary Range of Motion (both passive and active) A measurement of overall joint mobility of both lower extremities Screening, Baseline, Post 3-month home trials with each device
Secondary Six Minute Push Test A test to determine distance traveled in a wheelchair with self-propulsion over the course of 6 minutes. Baseline, Post 3-month home trials with each device
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT02845635 - MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis